Directive 2005/29/EC (as amended by Directive 2024/825/EU) is a lex generalis and serves as a “safety net” to protect consumers from any misleading commercial practices. It applies, in principle, to all products and services, and therefore also to over-the-counter medications, which are products purchased by consumers for personal use. Specific regulations governing the marketing of particular products take precedence (as lex specialis) in the event of a conflict.
Last modified on 08/10/2026